Baird R W upgraded shares of Beta Bionics (NASDAQ:BBNX – Free Report) to a hold rating in a research note published on Thursday morning,Zacks.com reports.
Several other analysts have also commented on BBNX. LADENBURG THALM/SH SH initiated coverage on Beta Bionics in a report on Thursday. They set a “neutral” rating and a $20.00 price objective for the company. Robert W. Baird started coverage on Beta Bionics in a research report on Thursday. They issued a “neutral” rating and a $20.00 target price on the stock.
Check Out Our Latest Stock Analysis on BBNX
Beta Bionics Stock Performance
Insider Activity at Beta Bionics
In related news, insider Mike Mensinger purchased 33,350 shares of the business’s stock in a transaction on Friday, January 31st. The shares were bought at an average cost of $17.00 per share, with a total value of $566,950.00. Following the transaction, the insider now owns 59,019 shares of the company’s stock, valued at approximately $1,003,323. This trade represents a 129.92 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder Hadley Harbor Aggre Wellington purchased 1,000,000 shares of the business’s stock in a transaction on Friday, January 31st. The shares were bought at an average cost of $17.00 per share, for a total transaction of $17,000,000.00. Following the completion of the transaction, the insider now directly owns 3,901,599 shares in the company, valued at $66,327,183. This trade represents a 34.46 % increase in their position. The disclosure for this purchase can be found here.
About Beta Bionics
Beta Bionics, Inc is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.
Further Reading
- Five stocks we like better than Beta Bionics
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Garmin’s Growth Signals Wearables Surge: Stocks to Watch
- P/E Ratio Calculation: How to Assess Stocks
- 3 Precious Metals ETFs Gaining Big as Gold Nears New Highs
- 3 Fintech Stocks With Good 2021 Prospects
- These 3 Defensive Retail Stocks Are Outpacing the Market
Receive News & Ratings for Beta Bionics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beta Bionics and related companies with MarketBeat.com's FREE daily email newsletter.